No Data
No Data
Truist Financial Maintains Summit Therapeutics(SMMT.US) With Buy Rating
Jefferies Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $31
Cantor Fitzgerald Maintains Summit Therapeutics(SMMT.US) With Buy Rating
Why Summit Therapeutics Inc. (SMMT) Went Up On Wednesday
Health Care Ticks Up Ahead of Earnings -- Health Care Roundup
Why Is Summit Therapeutics Stock Soaring On Wednesday?